Electronic Structure Study of Clopidogrel-Clonidine Complex

Authors

  • Breyner Ocampo Cárdenas Universidad Tecnológica Nacional, Facultad Regional Bahía Blanca. Bahía Blanca, Argentina.
  • Emilia Noseda Grau Universidad Tecnológica Nacional, Facultad Regional Bahía Blanca & Universidad Nacional del Sur, Departamento de Física & Instituto de Física del Sur (IFISUR), CONICET-UNS. Bahía Blanca, Argentina.
  • Gabriela Dodero Universidad Tecnológica Nacional, Facultad Regional Bahía Blanca & Universidad Nacional del Sur, Departamento de Física & Instituto de Física del Sur (IFISUR), CONICET-UNS. Bahía Blanca, Argentina.
  • Sandra Simonetti Universidad Tecnológica Nacional, Facultad Regional Bahía Blanca & Universidad Nacional del Sur, Departamento de Física & Instituto de Física del Sur (IFISUR), CONICET-UNS. Bahía Blanca, Argentina.

DOI:

https://doi.org/10.70567/mc.v42.ocsid8233

Keywords:

drug release, clopidogrel, clonidine, DFT

Abstract

The drugs clopidogrel and clonidine are frequently used to treat cardiovascular diseases. Since these drugs are commonly administered in combination, it is important to exam their molecular interactions. Therefore, chemical parameters were calculated using Gaussian 09 software. The study was complemented by infrared (IR) spectra, NBO charges, molecular electrostatic potential (MEP) map, and total density of states (TDOS) plots. The results of the NBO, MEP, and TDOS analysis predict a physical-like bond between the drugs. The lowest energy for the clopidogrel-clonidine interaction is achieved through the formation of four hydrogen bonds observed in the IR spectrum. Hydrogen bonds play a crucial role in controlled drug release, allowing moderate and reversible adsorption, facilitating drug release into the biological environment. The IR spectrum, on the other hand, supports the absence of drug degradation, confirming the preservation of the individual active pharmaceutical ingredient.

References

Castellano J.M., Pocock S.J., Bhatt D.L., Quesada A.J., Owen R., Fernandez-Ortiz A., y Sanchez P.L. Polypill strategy in secondary cardiovascular prevention. New England Journal of Medicine, 387:967–977, 2022. https://doi.org/10.1056/nejmoa2208275

Cesare M.D., Perel P., Taylor S., Kabudula C., Bixby H., Gaziano T.A., McGhie D.V., Mwangi J., Pervan B., Narula J., Pineiro D., y Pinto F.J. The heart of the world. Global Heart, 19(1):11, 2024. https://doi.org/10.5334/gh.1288

ClinCalc. Top 200 drugs. https://clincalc.com/DrugStats/Top200Drugs.aspx, 2023.Accessed: 2024-08-24.

Cossi M., Barone V., Cammi R., y Tomasi J. Ab initio study of solvated molecules: A new implementation of the polarizable continuum model. Chemical Physics Letters, 255:327– 335, 1996. https://doi.org/10.1016/0009-2614(96)00349-1

Dastani N., Arab A., y Raissi H. Adsorption of ampyra anticancer drug on the graphene and functionalized graphene as template materials with high efficient carrier. Adsorption, 26:879–893, 2020. https://doi.org/10.1007/s10450-019-00142-1

Dennington R., Keith T., Millam J., et al. Gaussview 5.0, gaussian. Inc., Wallingford, 20, 2008a.

D’Sa S. y Machin S.J. Clopidogrel, a novel antiplatelet agent. Hospital Medicine, 60(5):362– 363, 1990. https://doi.org/10.12968/hosp.1999.60.5.1117

Frisch M.J., Trucks G.W., Schlegel H.B., Scuseria G.E., Robb M.A., Cheeseman J.R., Scalmani G., Barone V., Mennucci B., Petersson G.A., Nakatsuji H., Caricato M., Li X., Hratchian H.P., Izmaylov A.F., Bloino J., Zheng G., Sonnenberg J.L., Hada M., Ehara M., Toyota K., Fukuda R., Hasegawa J., Ishida M., Nakajima T., Honda Y., Kitao O., Nakai H., Vreven T., J. A. Montgomery J., Peralta J.E., Ogliaro F., Bearpark M., Heyd J.J., Brothers E., Kudin K.N., Staroverov V.N., Kobayashi R., Normand J., Raghavachari K., Rendell A., Burant J.C., Iyengar S.S., Tomasi J., Cossi M., Rega N., Millam J.M., Klene M., Knox J.E., Cross J.B., Bakken V., Adamo C., Jaramillo J., Gomperts R., Stratmann R.E., Yazyev O., Austin A.J., Cammi R., Pomelli C., Ochterski J.W., Martin R.L., Morokuma K., Zakrzewski V.G., Voth G.A., Salvador P., Dannenberg J.J., Dapprich S., Daniels A.D., Farkas O., Foresman J.B., Ortiz J.V., Cioslowski J., y Fox D.J. Gaussian 09, revision a.02. 2009.

Krzywanski J., Sosnowski M., Grabowska K., Zylka A., Lasek L., y Kijo-Kleczkowska A. Advanced computational methods for modeling, prediction and optimization—a review. Materials, 17:3521, 2024. https://doi.org/10.3390/ma17143521

Simonetti M.P.B., Valinetti E.A., y Ferreira F.M.C. Clonidine: from nasal descongestive to potent analgesic. historical and pharmacological considerations. Revista Brasileira de Anestesiologia, 47:37–47, 1997.

Published

2025-12-05

Issue

Section

Conference Papers in MECOM 2025

Most read articles by the same author(s)